Annual CFO
-$145.30 M
-$11.03 M-8.21%
December 1, 2024
Summary
- As of March 13, 2025, CGEM annual cash flow from operations is -$145.30 million, with the most recent change of -$11.03 million (-8.21%) on December 1, 2024.
- During the last 3 years, CGEM annual CFO has fallen by -$101.87 million (-234.55%).
Performance
CGEM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$36.63 M
-$2.49 M-7.28%
December 1, 2024
Summary
- As of March 13, 2025, CGEM quarterly cash flow from operations is -$36.63 million, with the most recent change of -$2.49 million (-7.28%) on December 1, 2024.
- Over the past year, CGEM quarterly CFO has stayed the same.
- CGEM quarterly CFO is now -2317.56% below its all-time high of -$1.51 million, reached on March 31, 2021.
Performance
CGEM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$145.30 M
-$18.50 M-14.59%
December 1, 2024
Summary
- As of March 13, 2025, CGEM TTM cash flow from operations is -$145.30 million, with the most recent change of -$18.50 million (-14.59%) on December 1, 2024.
- Over the past year, CGEM TTM CFO has stayed the same.
- CGEM TTM CFO is now -2797.37% below its all-time high of -$5.01 million, reached on March 31, 2020.
Performance
CGEM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CGEM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.2% | 0.0% | 0.0% |
| 3 y3 years | -234.6% | -141.4% | -234.6% |
| 5 y5 years | -595.3% | - | - |
CGEM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -234.6% | at low | -141.4% | +32.6% | -234.6% | +9.9% |
| 5 y | 5-year | -595.3% | at low | -2317.6% | +32.6% | -2797.4% | +9.9% |
| alltime | all time | <-9999.0% | at low | -2317.6% | +32.6% | -2797.4% | +9.9% |
Cullinan Oncology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$145.30 M(+8.2%) | -$36.63 M(+7.3%) | -$145.30 M(+14.6%) |
| Sep 2024 | - | -$34.14 M(-5.9%) | -$126.81 M(-0.0%) |
| Jun 2024 | - | -$36.29 M(-5.1%) | -$126.81 M(+4.3%) |
| Mar 2024 | - | -$38.25 M(+110.9%) | -$121.53 M(-9.5%) |
| Dec 2023 | -$134.28 M(+6.0%) | -$18.13 M(-46.9%) | -$134.28 M(-4.9%) |
| Sep 2023 | - | -$34.14 M(+10.1%) | -$141.13 M(-12.5%) |
| Jun 2023 | - | -$31.01 M(-39.2%) | -$161.34 M(+3.6%) |
| Mar 2023 | - | -$51.00 M(+104.1%) | -$155.75 M(+23.0%) |
| Dec 2022 | -$126.66 M(+191.6%) | -$24.98 M(-54.0%) | -$126.66 M(+8.4%) |
| Sep 2022 | - | -$54.35 M(+113.8%) | -$116.85 M(+60.0%) |
| Jun 2022 | - | -$25.42 M(+16.0%) | -$73.05 M(+14.5%) |
| Mar 2022 | - | -$21.91 M(+44.4%) | -$63.83 M(+47.0%) |
| Dec 2021 | -$43.43 M(+45.9%) | -$15.17 M(+43.8%) | -$43.43 M(+15.2%) |
| Sep 2021 | - | -$10.55 M(-34.9%) | -$37.70 M(+4.1%) |
| Jun 2021 | - | -$16.20 M(+969.0%) | -$36.22 M(+37.9%) |
| Mar 2021 | - | -$1.51 M(-83.9%) | -$26.27 M(-11.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$29.77 M(+42.5%) | -$9.44 M(+4.0%) | -$29.77 M(+46.4%) |
| Sep 2020 | - | -$9.07 M(+45.1%) | -$20.34 M(+80.5%) |
| Jun 2020 | - | -$6.25 M(+24.6%) | -$11.27 M(+124.6%) |
| Mar 2020 | - | -$5.01 M | -$5.01 M |
| Dec 2019 | -$20.90 M(+54.2%) | - | - |
| Dec 2018 | -$13.55 M(+7856.0%) | - | - |
| Dec 2016 | -$170.30 K(+840.9%) | - | - |
| Dec 2015 | -$18.10 K(-78.1%) | - | - |
| Dec 2014 | -$82.80 K(-88.1%) | - | - |
| Dec 2013 | -$695.60 K(+382.1%) | - | - |
| Dec 2012 | -$144.30 K(-13.0%) | - | - |
| Dec 2011 | -$165.90 K(-81.5%) | - | - |
| Dec 2010 | -$895.80 K(+206.5%) | - | - |
| Dec 2009 | -$292.30 K(+700.8%) | - | - |
| Dec 2008 | -$36.50 K(<-9900.0%) | - | - |
| Dec 2007 | $0.00 | - | - |
FAQ
- What is Cullinan Oncology annual cash flow from operations?
- What is the all time high annual CFO for Cullinan Oncology?
- What is Cullinan Oncology annual CFO year-on-year change?
- What is Cullinan Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cullinan Oncology?
- What is Cullinan Oncology quarterly CFO year-on-year change?
- What is Cullinan Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Cullinan Oncology?
- What is Cullinan Oncology TTM CFO year-on-year change?
What is Cullinan Oncology annual cash flow from operations?
The current annual CFO of CGEM is -$145.30 M
What is the all time high annual CFO for Cullinan Oncology?
Cullinan Oncology all-time high annual cash flow from operations is $0.00
What is Cullinan Oncology annual CFO year-on-year change?
Over the past year, CGEM annual cash flow from operations has changed by -$11.03 M (-8.21%)
What is Cullinan Oncology quarterly cash flow from operations?
The current quarterly CFO of CGEM is -$36.63 M
What is the all time high quarterly CFO for Cullinan Oncology?
Cullinan Oncology all-time high quarterly cash flow from operations is -$1.51 M
What is Cullinan Oncology quarterly CFO year-on-year change?
Over the past year, CGEM quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Cullinan Oncology TTM cash flow from operations?
The current TTM CFO of CGEM is -$145.30 M
What is the all time high TTM CFO for Cullinan Oncology?
Cullinan Oncology all-time high TTM cash flow from operations is -$5.01 M
What is Cullinan Oncology TTM CFO year-on-year change?
Over the past year, CGEM TTM cash flow from operations has changed by $0.00 (0.00%)